Holen Sie sich die Stockscreener-App
2.43
0.00%
0.00
Handel nachbörslich:
2.44
0.010
+0.41%
Schlusskurs vom Vortag:
$2.43
Offen:
$2.5
24-Stunden-Volumen:
230.28K
Relative Volume:
1.74
Marktkapitalisierung:
$244.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-60.14M
KGV:
-3.4249
EPS:
-0.7095
Netto-Cashflow:
$-68.17M
1W Leistung:
+17.39%
1M Leistung:
+17.39%
6M Leistung:
-10.99%
1J Leistung:
-37.85%
1-Tages-Spanne:
$2.32
$2.52
1-Wochen-Bereich:
$2.07
$2.52
52-Wochen-Spanne:
$1.4299
$4.26
Ac Immune Sa Stock (ACIU) Company Profile
Vergleichen Sie ACIU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.43 | 244.46M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-31 | Eingeleitet | BTIG Research | Buy |
| 2019-02-01 | Herabstufung | UBS | Buy → Neutral |
| 2019-01-04 | Eingeleitet | UBS | Buy |
| 2018-04-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-23 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-10-18 | Eingeleitet | Credit Suisse | Outperform |
| 2016-10-18 | Eingeleitet | Jefferies | Buy |
| 2016-10-18 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Ac Immune Sa Aktie (ACIU) Neueste Nachrichten
What institutional investors are buying AC Immune SA stockPowerful growth strategies - jammulinksnews.com
What makes AC Immune SA stock price move sharplyBest Stocks for Capital Safety - Newser
AC Immune SA Stock Performance After Earnings: Historical InsightsGrowth Optimized Stock Radar - Newser
Will AC Immune SA stock split in the near futureSmart Trading With Safety Margin - Newser
Top Risks to Consider Before Buying AC Immune SA StockTrend Following Trades - Newser
Key External Factors That Drive AC Immune SA Stock Price MovementsFree Stock Market Practical Discussion Forums - Newser
What analysts say about AC Immune SA stockConsistent high-performance stocks - PrintWeekIndia
What drives AC Immune SA stock pricePhenomenal investment performance - Autocar Professional
Is AC Immune SA a good long term investmentExceptional gains - Autocar Professional
Can AC Immune SA stock recover from recent declineHigh-yield growth strategies - jammulinksnews.com
Is AC Immune SA stock a growth or value playDynamic growth stocks - jammulinksnews.com
Published on: 2025-07-23 19:50:12 - jammulinksnews.com
AC Immune SA Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com
AC Immune patent discloses new NLRP3 inflammasome inhibitors - BioWorld MedTech
How AC Immune SA stock performs during market volatilityRisk Managed Trading Strategy - Newser
Why AC Immune SA stock attracts strong analyst attentionBig Return Stock Tips - Newser
Encoding an entire mAb against TDP-43 into AAV to treat neurodegenerative diseases - BioWorld MedTech
AC Immune SA Announces Board Changes Ahead of June 2025 AGM - TipRanks
Finanzdaten der Ac Immune Sa-Aktie (ACIU)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):